Abbvie Inc

NYSE: ABBV
$166.28
+$1.29 (+0.8%)
Closing Price on November 18, 2024

ABBV Articles

Long-term growth investors looking for a degree of safety and value should consider some of these outstanding companies. While the sentiment may be less than stellar now, massive drug pricing changes...
For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made a couple additions and updated its price target information.
The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest decreased.
In a recent research report, Jefferiesfocused on some large cap stocks that are still trading way below their 52-week highs.
The top analyst upgrades, downgrades and initiations seen from Monday, March 7, include Enbridge, Micron Technology, Sun Life Financial, Starbucks, Stratasys and Wynn Resorts.
The top analyst upgrades, downgrades and initiations seen from Friday, February 26, include American Water Works, Autodesk, Kraft Heinz, Palo Alto Networks, Toyota and Vipshop.
The February 12 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.
These stocks make good sense for long-term patient investors that have a growth and income total return bias in their portfolios.
The top analyst upgrades, downgrades and initiations seen on Tuesday, February 23, include Annaly Capital Management, Barrick Gold, Cheniere Energy, Fitbit, Dean Foods, Groupon, SolarCity, Twitter...
In a new research report, Jefferies shuffles some of the pharmaceutical stocks in its coverage universe and a beaten-down dividend leader is now the top pick globally.
The top analyst upgrades, downgrades and initiations seen on Monday, February 22, include AbbVie, Deere, Expedia, Hewlett Packard Enterprise, JPMorgan and Phillips 66.
For worried investors that need an income stream, all these top stocks make good sense for growth and income portfolios.
One thing that the recent sell-off has accomplished is to take top companies residing in the Jefferies Franchise Picks list to levels not seen in some time.
The January 29 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.
If you ever want to look for value in a sector in the stock market, then when you see Congress calling in some of the top companies to scold them for political purposes, you may want to start buying.